- Exhibit & Support
- Hotel & Travel
Should naloxone be dispensed with every opioid prescription? Has limited prescribing of opioids proven effective at reducing substance use disorders? Is medical cannabis safer than opioids for pain? When is it appropriate to adapt evidence-based treatment recommendations to meet the chronic pain management needs of individual patients? Are prescription drug monitoring programs effective in decreasing overdose deaths?
For pharmacists, the answers aren’t always black and white. Come to this session to hear experts lay out their arguments on these timely topics.
Pre-registration is required; registration is open at http://elearning.pharmacist.com/products/5335/apha2019-pain-institute-innovative-approaches-to-chronic-pain .
At the completion of this knowledge-based activity, participants will be able to: